SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Caroline M. Tanner, Cheryl C. Meng, Bernard Ravina, Anthony Lang, Roger Kurlan, Kenneth Marek, David Oakes, John Seibyl, Emily Flagg, Lisa Gauger, Dolores D. Guest, Christopher G. Goetz, Karl Kieburtz, Diane DiEuliis, Stanley Fahn, Robin A. Elliott, Ira Shoulson, A practical approach to remote longitudinal follow-up of Parkinson's disease: The FOUND study, Movement Disorders, 2014, 29, 6
  2. 2
    Inger van Steenoven, Dag Aarsland, Howard Hurtig, Alice Chen-Plotkin, John E. Duda, Jacqueline Rick, Lama M. Chahine, Nabila Dahodwala, John Q. Trojanowski, David R. Roalf, Paul J. Moberg, Daniel Weintraub, Conversion between Mini-Mental State Examination, Montreal Cognitive Assessment, and Dementia Rating Scale-2 scores in Parkinson's disease, Movement Disorders, 2014, 29, 14
  3. 3
    Jamie M Sheard, Susan Ash, George D Mellick, Peter A Silburn, Graham K Kerr, Improved nutritional status is related to improved quality of life in Parkinson’s disease, BMC Neurology, 2014, 14, 1

    CrossRef

  4. 4
    Nagaendran Kandiah, Angeline Zhang, Alvin Rae Cenina, Wing Lok Au, Nivedita Nadkarni, Louis Cs Tan, Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease, Parkinsonism & Related Disorders, 2014, 20, 11, 1145

    CrossRef

  5. 5
    Pablo Martinez-Martin, Nonmotor symptoms and health-related quality of life in early Parkinson's disease, Movement Disorders, 2014, 29, 2
  6. 6
    Daniel J. Burdick, Brenna Cholerton, G.S. Watson, Andrew Siderowf, John Q. Trojanowski, Daniel Weintraub, Beate Ritz, Shannon L. Rhodes, Renecca Rausch, Stewart A. Factor, Cathy Wood-Siverio, Joseph F. Quinn, Kathryn A. Chung, Sindhu Srivatsal, Karen L. Edwards, Thomas J. Montine, Cyrus P. Zabetian, James B. Leverenz, People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance, Movement Disorders, 2014, 29, 10
  7. 7
    Jane Simpson, Godwin Lekwuwa, Trevor Crawford, Predictors of quality of life in people with Parkinson’s disease: evidence for both domain specific and general relationships, Disability and Rehabilitation, 2014, 36, 23, 1964

    CrossRef

  8. 8
    P. Martínez-Martín, C. Rodríguez-Blázquez, M. J. Forjaz, M. Álvarez-Sánchez, T. Arakaki, A. Bergareche-Yarza, A. Chade, N. Garretto, O. Gershanik, M. M. Kurtis, J. C. Martínez-Castrillo, A. Mendoza-Rodríguez, H. P. Moore, M. Rodríguez-Violante, C. Singer, B. C. Tilley, J. Huang, G. T. Stebbins, C. G. Goetz, Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients , European Journal of Neurology, 2014, 21, 3
  9. 9
    Simon Eggington, Francesc Valldeoriola, K. Ray Chaudhuri, Keyoumars Ashkan, Elena Annoni, Günther Deuschl, The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson’s disease, Journal of Neurology, 2014, 261, 1, 106

    CrossRef

  10. 10
    Betul Ozdilek, Gulay Kenangil, Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in Patients With Parkinson’s Disease, The Clinical Neuropsychologist, 2014, 28, 2, 333

    CrossRef

  11. 11
    Nir Giladi, Fay B. Horak, Jeffrey M. Hausdorff, Classification of gait disturbances: Distinguishing between continuous and episodic changes, Movement Disorders, 2013, 28, 11
  12. 12
    Walter Maetzler, Freek Nieuwhof, Sandra E. Hasmann, Bastiaan R. Bloem, Emerging therapies for gait disability and balance impairment: Promises and pitfalls, Movement Disorders, 2013, 28, 11
  13. 13
    Gregory M. Pontone, Justin Palanci, James R. Williams, Susan Spear Bassett, Screening for DSM-IV-TR cognitive disorder NOS in Parkinson's disease using the Mattis Dementia Rating Scale, International Journal of Geriatric Psychiatry, 2013, 28, 4
  14. 14
    Sheila M. Fleming, Tim Schallert, Michelle R. Ciucci, Cranial and related sensorimotor impairments in rodent models of Parkinson's disease, Behavioural Brain Research, 2012, 231, 2, 317

    CrossRef

  15. 15
    T.S. Voss, J.J. Elm, C.L. Wielinski, M.J. Aminoff, D. Bandyopadhyay, K.L. Chou, L.R. Sudarsky, B.C. Tilley, Fall frequency and risk assessment in early Parkinson's disease, Parkinsonism & Related Disorders, 2012, 18, 7, 837

    CrossRef

  16. 16
    I. Leroi, D. J. Ahearn, M. Andrews, K. R. McDonald, E. J. Byrne, A. Burns, Behavioural disorders, disability and quality of life in Parkinson's disease, Age and Ageing, 2011, 40, 5, 614

    CrossRef

  17. 17
    Jonathan R Evans, Roger A Barker, Defining meaningful outcome measures in trials of disease-modifying therapies in Parkinson's disease, Expert Opinion on Pharmacotherapy, 2011, 12, 8, 1249

    CrossRef

  18. 18
    Yaroslav Winter, Sonja von Campenhausen, Martin Arend, Katia Longo, Kai Boetzel, Karla Eggert, Wolfgang H. Oertel, Richard Dodel, Paolo Barone, Health-related quality of life and its determinants in Parkinson’s disease: Results of an Italian cohort study, Parkinsonism & Related Disorders, 2011, 17, 4, 265

    CrossRef

  19. 19
    Juan Carlos Gómez-Esteban, Beatriz Tijero, Johanne Somme, Roberto Ciordia, Koldo Berganzo, Idoia Rouco, Jose Luis Bustos, Maria Antonia Valle, Elena Lezcano, Juan J. Zarranz, Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson’s disease, Journal of Neurology, 2011, 258, 3, 494

    CrossRef

  20. 20
    Irene Litvan, Dag Aarsland, Charles H. Adler, Jennifer G. Goldman, Jaime Kulisevsky, Brit Mollenhauer, Maria C. Rodriguez-Oroz, Alexander I. Tröster, Daniel Weintraub, MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI, Movement Disorders, 2011, 26, 10
  21. 21
    Bart Post, Dino Muslimovic, Nan van Geloven, Johannes D. Speelman, Ben Schmand, Rob J. de Haan, Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease, Movement Disorders, 2011, 26, 3
  22. 22
    Pablo Martinez-Martin, Carmen Rodriguez-Blazquez, Monica M. Kurtis, K. Ray Chaudhuri, The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease, Movement Disorders, 2011, 26, 3
  23. 23
    Pablo Martinez-Martin, The importance of non-motor disturbances to quality of life in Parkinson's disease, Journal of the Neurological Sciences, 2011, 310, 1-2, 12

    CrossRef

  24. 24
    Jens Klotsche, Jens Peter Reese, Yaroslav Winter, Wolfgang H. Oertel, Hyacinth Irving, Hans-Ulrich Wittchen, Juergen Rehm, Richard Dodel, Trajectory Classes of Decline in Health-Related Quality of Life in Parkinson's Disease: A Pilot Study, Value in Health, 2011, 14, 2, 329

    CrossRef

  25. 25
    T. Ellis, J.T. Cavanaugh, G.M. Earhart, M.P. Ford, K.B. Foreman, L.E. Dibble, Which measures of physical function and motor impairment best predict quality of life in Parkinson’s disease?, Parkinsonism & Related Disorders, 2011, 17, 9, 693

    CrossRef

  26. 26
    Randolph Stephenson, David Houghton, Sri Sundarararjan, Richard L. Doty, Matthew Stern, Sharon X. Xie, Andrew Siderowf, Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease, Movement Disorders, 2010, 25, 13
  27. 27
    Yaroslav Winter, Sonja von Campenhausen, Georgy Popov, Jens P. Reese, Monika Balzer-Geldsetzer, Anastasia Kukshina, Tatyana V. Zhukova, Natalia Bertschi, Kai Bötzel, Eugene Gusev, Wolfgang H. Oertel, Richard Dodel, Alla Guekht, Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study, Parkinsonism & Related Disorders, 2010, 16, 4, 243

    CrossRef

  28. 28
    Yaroslav Winter, Sonja Campenhausen, Julia Gasser, Klaus Seppi, Jens-P. Reese, Karl-P. Pfeiffer, Kai Bötzel, Wolfgang H. Oertel, Richard Dodel, Werner Poewe, Social and clinical determinants of quality of life in Parkinson’s disease in Austria: a cohort study, Journal of Neurology, 2010, 257, 4, 638

    CrossRef

  29. 29
    M.-U. Ferraye, B. Debû, P. Pollak, Stimulation cérébrale profonde et troubles de la marche dans la maladie de Parkinson, Revue Neurologique, 2010, 166, 2, 178

    CrossRef

  30. 30
    B. Hanna-Pladdy, A. Enslein, M. Fray, B. J. Gajewski, R. Pahwa, K. E. Lyons, Utility of the NeuroTrax Computerized Battery for Cognitive Screening in Parkinson's Disease: Comparison with the MMSE and the MoCA, International Journal of Neuroscience, 2010, 120, 8, 538

    CrossRef

  31. 31
    Marcos Hortes Nisihara Chagas, Vitor Tumas, Sonia Regina Loureiro, Jaime E.C. Hallak, Clarissa Trzesniak, João Paulo Machado de Sousa, Guilherme Gustavo Ricciopo Rodrigues, Alaor Santos Filho, José Alexandre S. Crippa, Validity of a Brazilian version of the Zung self-rating depression scale for screening of depression in patients with Parkinson's disease, Parkinsonism & Related Disorders, 2010, 16, 1, 42

    CrossRef

  32. 32
    Martine Visser, Dagmar Verbaan, Stephanie Van Rooden, Johan Marinus, Johannes Van Hilten, Anne Stiggelbout, A Longitudinal Evaluation of Health-Related Quality of Life of Patients with Parkinson's Disease, Value in Health, 2009, 12, 2
  33. 33
    Kathleen M. Fitzpatrick, James Raschke, Marina E. Emborg, Cell-Based Therapies for Parkinson's Disease: Past, Present, and Future, Antioxidants & Redox Signaling, 2009, 11, 9, 2189

    CrossRef

  34. 34
    Michelle Renee Ciucci, Nadine P. Connor, Dopaminergic influence on rat tongue function and limb movement initiation, Experimental Brain Research, 2009, 194, 4, 587

    CrossRef

  35. 35
    Madeleine E. Hackney, Gammon M. Earhart, Health-related quality of life and alternative forms of exercise in Parkinson disease, Parkinsonism & Related Disorders, 2009, 15, 9, 644

    CrossRef

  36. 36
    Anne Soeder, Benzi M. Kluger, Michael S. Okun, Cynthia W. Garvan, Thomas Soeder, Charles E. Jacobson, Ramon L. Rodriguez, Rick Turner, Hubert H. Fernandez, Mood and energy determinants of quality of life in dystonia, Journal of Neurology, 2009, 256, 6, 996

    CrossRef

  37. 37
    D. M. Schiehser, S. D. Han, S. Lessig, D. D. Song, V. Zizak, J. V. Filoteo, Predictors of Health Status in Nondepressed and Nondemented Individuals with Parkinson's Disease, Archives of Clinical Neuropsychology, 2009, 24, 7, 699

    CrossRef

  38. 38
    Walter Maetzler, Inga Liepelt, Daniela Berg, Progression of Parkinson's disease in the clinical phase: potential markers, The Lancet Neurology, 2009, 8, 12, 1158

    CrossRef

  39. 39
    Cory L. Christiansen, Margaret L. Schenkman, Kim McFann, Pamela Wolfe, Wendy M. Kohrt, Walking economy in people with Parkinson's disease, Movement Disorders, 2009, 24, 10
  40. 40
    THOMAS R. COLLINS, Biomarkers for Dementia in PD Gleaned from DATATOP Study, Neurology Today, 2008, 8, 23, 3

    CrossRef

  41. 41
    David A Gallagher, Anette Schrag, Impact of Newer Pharmacological Treatments on Quality of Life in Patients with Parkinson???s Disease, CNS Drugs, 2008, 22, 7, 563

    CrossRef

  42. 42
    Karl Kieburtz, Clinical Trial Measures of the Non-Motor Features of Parkinson's Disease,
  43. 43
    Tiffini Voss, Irene Hegeman Richard, Depression in Parkinson's Disease,
  44. 44
    Yvette A. M. Grimbergen, Arlène D. Speelman, Marjolein A. van der Marck, Yvonne Schoon, Bastiaan R. Bloem, Gait, Postural Instability, and Freezing,